Morphic to Participate in March Investor Conferences

WALTHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology institution processing a caller procreation of oral integrin therapies for nan curen of superior chronic diseases, coming announced its information astatine investor conferences during nan period of March.

3/6/24

9:10 AM ET

GI/Microbiome Panel Discussion astatine nan TD Cowen 44th Annual Health Care Conference

10:30 AM ET

Fireside Chat astatine nan TD Cowen 44th Annual Health Care Conference

3/13/24

Jefferies Biotech connected nan Bay Summit

and

Leerink Partners 2024 Global Biopharma Conference

A unrecorded webcast of nan sheet chat and fireside chat astatine nan TD Cowen 44th Annual Health Care Conference will beryllium disposable connected nan Investor conception of Morphic’s website astatine www.morphictx.com. An archived replay will beryllium disposable connected nan company’s website pursuing nan conference.

About Morphic Therapeutic

Morphic Therapeutic is simply a biopharmaceutical institution processing a portfolio of oral integrin therapies for nan curen of superior chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Morphic is besides advancing its pipeline and find activities successful collaboration pinch Schrödinger utilizing its proprietary MInT exertion level which leverages nan Company’s unsocial knowing of integrin building and biology. For much information, sojourn www.morphictx.com.

Contacts

Morphic Therapeutic

Chris Erdman

[email protected]

617.686.1718